BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 4138057)

  • 21. [Serum prostatic acid phosphatase].
    Chen M; Gai M; Fishelovitz J; Hegesh E
    Harefuah; 1983 May; 104(9):378-80. PubMed ID: 6674043
    [No Abstract]   [Full Text] [Related]  

  • 22. [Fundamental and clinical study of PAP 'Eiken' (author's transl)].
    Higuchi Y; Kida T
    Kaku Igaku; 1981 Dec; 18(10):1451-7. PubMed ID: 6176743
    [No Abstract]   [Full Text] [Related]  

  • 23. Prostatic acid phosphatase and prostatic cancer.
    Foti AG; Cooper JF; Herschman H
    Recent Results Cancer Res; 1979; 67():45-9. PubMed ID: 88065
    [No Abstract]   [Full Text] [Related]  

  • 24. [The clinical and prognostic value of inversion of the PSA/PAP ratio in prostatic cancer].
    Morote Robles J; Lorente JA; Reig C; López Pacios MA; de Torres JA; Soler Roselló A
    Actas Urol Esp; 1994 May; 18(5):559-61. PubMed ID: 7521563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Contribution on the clinical aspects of prostatic carcinoma].
    Sladczyk E
    Z Arztl Fortbild (Jena); 1967 Jul; 61(13):657-60. PubMed ID: 5598256
    [No Abstract]   [Full Text] [Related]  

  • 26. [Changes in acid phosphatase levels during various prostatic operations].
    Vitsou-Georgallis H; Goulandris N; Marketos N; Dimopoulos C
    Acta Urol Belg; 1980 Oct; 48(4):488-97. PubMed ID: 6161530
    [No Abstract]   [Full Text] [Related]  

  • 27. [Value of commercial enzyme immunoassays in the determination of prostatic acid phosphatase].
    Rassweiler J; Lutz K; Müller HA; Eisenberger F
    Urologe A; 1988 Jan; 27(1):32-5. PubMed ID: 2452506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Radioimmunoassay for prostatic acid phosphatase in human serum. Methodologic aspects (author's transl)].
    Pradalier N; Canal P; Pujol A; Fregevu Y; Soula G
    Ann Biol Clin (Paris); 1982; 40(1):45-50. PubMed ID: 7200750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of a double antibody radioimmunoassay kit for prostatic acid phosphatase (PAP) (author's transl)].
    Yoshii M; Kousaka T; Morita R; Torizuka K; Kawamura J
    Kaku Igaku; 1981 Dec; 18(10):1473-83. PubMed ID: 6176744
    [No Abstract]   [Full Text] [Related]  

  • 30. Expression of human prostatic acid phosphatase and prostate specific antigen genes in neoplastic and benign tissues.
    Sharief FS; Mohler JL; Sharief Y; Li SS
    Biochem Mol Biol Int; 1994 Jun; 33(3):567-74. PubMed ID: 7524903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoreactive prostate-specific acid phosphatase in prostatic cancer.
    Kontturi M; Vihko P; Lukkarinen O; Vihko R
    Scand J Clin Lab Invest Suppl; 1985; 179():67-74. PubMed ID: 3866311
    [No Abstract]   [Full Text] [Related]  

  • 32. Metastatic prostate carcinoma to the mandible: report of case.
    Mesa ML
    J Oral Surg; 1977 Feb; 35(2):133-5. PubMed ID: 264506
    [No Abstract]   [Full Text] [Related]  

  • 33. [Significance of an immunoenzyme assay of the prostate-specific acid phosphatase (PAP) (E.C.3.1.3.2.) in prostatic carcinoma. Methods and initial clinical results].
    Bauer HW; Schmiedt E
    Urologe A; 1983 Sep; 22 Suppl():367-71. PubMed ID: 6195796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of biochemical technique and radioimmunoassay for the measurement of serum prostatic acid phosphatase. Interest in the diagnosis of prostatic cancer?
    Canal P; Soula G
    Pathol Biol (Paris); 1982 Dec; 30(10):833-6. PubMed ID: 6185909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical aspects of prostatic carcinoma.
    Foo KT; Tan EC; Tung KH; Lee YS
    Singapore Med J; 1982 Oct; 23(5):269-72. PubMed ID: 7157007
    [No Abstract]   [Full Text] [Related]  

  • 36. [The diagnostic value of radiological, nuclear medicine and biochemical methods for detection of bone metastases in carcinoma of the prostate (author's transl)].
    Rost A; Fiedler U; Marshall F; Koppenhagen K
    Radiologe; 1977 Jun; 17(6):249-55. PubMed ID: 887744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Critical study of acid phosphatases in benign prostatic hypertrophy].
    Rodrigues Netto Júnior N; de Andrade AC; Lemos GC; de Araujo JT
    AMB Rev Assoc Med Bras; 1982; 28(3-4):93-5. PubMed ID: 6189151
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of manipulation of the prostate gland on serum prostate-specific acid phosphatase measured by radioimmunoassay.
    Vihko P; Lukkarinen O; Kontturi M; Vihko R
    Invest Urol; 1981 Mar; 18(5):334-6. PubMed ID: 6162819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occult carcinoma of the prostate.
    El-Morsi AR
    J Egypt Med Assoc; 1974; 57(7-8):373-7. PubMed ID: 4452775
    [No Abstract]   [Full Text] [Related]  

  • 40. The radioimmunochemical measurement of prostatic acid phosphatase: current state of the art.
    Cooper JF
    Urol Clin North Am; 1980 Oct; 7(3):653-65. PubMed ID: 6161460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.